Cushing’s Syndrome and Acromegaly Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Increasing investment in research and development for better healthcare treatments is anticipated to drive the growth of Global Cushing’s Syndrome and Acromegaly Treatment Market.
Global Cushing’s Syndrome and Acromegaly Treatment Market is expected grow at a CAGR of 8.92% over the forecast period.
Cushing syndrome occurs due to abnormally high levels of the hormone cortisol. It is all about the stress hormone cortisol. This condition, also known as hypercortisolism and affects about three times as many women as men. It’s most often seen in people ages 25 to 40. It occurs when body is exposed to high levels of the hormone cortisol for a long time. It may be caused by the use of oral corticosteroid medication. In this condition body makes too much of the hormone cortisol over a long period of time. It can cause health problems such as: heart attack and stroke, blood clots in the legs and lungs, infections, bone loss and fractures, high blood pressure, unhealthy cholesterol levels, depression or other mood changes, memory loss or trouble concentrating, insulin resistance and prediabetes and type 2 diabetes.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=141615&RequestType=Sample
Acromegaly is a hormonal disorder that results from too much growth hormone in the body. In this condition, pituitary produces excessive amounts of growth hormone. Usually the excess GH comes from benign, or noncancerous, tumors on the pituitary. When this happens, bones increase in size, including those of patient’s hands, feet and face. It majorly affects middle-aged adults, though it can develop at any age. Increasing prevalence of Cushing’s Syndrome and Acromegaly and growing adoption of new methods of treatments are major factors driving the market growth.
Global cushing’s syndrome and acromegaly treatment market report is segmented on the basis of drug type, sales channel and region & country level. Based upon drug type, global cushing’s syndrome treatment is classified into somatostatin, glucocorticoid receptor inhibitors, ketoconazole hra and other off-label and acromegaly treatment is classified into glucocorticoid receptor inhibitors, somatostatin and other off-label. Based on sales channel, the cushing’s syndrome and acromegaly treatment market is classified into retail pharmacies, hospital pharmacies and online pharmacies.
The regions covered in this Cushing’s Syndrome and Acromegaly Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of Cushing’s Syndrome and Acromegaly Treatment is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Key Players for Global Cushing’s Syndrome and Acromegaly Treatment Market Report–
Some major key players for global cushing’s syndrome and acromegaly treatment market are Corcept Therapeutics, Ipsen Biopharmaceuticals, Inc., HRA Pharma, Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc. and others.
News-
ACTH Levels After Surgery Help Predict Remission, Recurrence in Cushing’s, Study Suggests.
August 29th, 2019; The study, “Prognostic usefulness of ACTH in the postoperative period of Cushing’s disease,” was published in the journal Endocrine Connections. Levels of adrenocorticotropic hormone (ACTH) in circulation after pituitary surgery may help predict which Cushing’s disease patients will achieve early remission and which will eventually see the disease return, a study shows. Also, the earlier that patients reached their lowest peak of ACTH levels, the better their long-term outcomes..
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=141615&RequestType=Methodology
Increasing Awareness, Increasing Investments in the Research and Development and Growing Adoption of New Treatments are the Major Factors Driving the Market Growth.
The major factors driving the growth of global cushing’s syndrome and acromegaly treatment market are the prevalence of cushing’s syndrome and acromegaly and increasing government initiatives for the treatment of Cushing’s syndrome and Acromegaly. For example; American Association of Neurological Surgeons; An estimated 10-15 per million people are affected every year. Pituitary adenomas (Cushing’s disease) account for more than 70 percent of cases in adults and about 60-70 percent of cases in children and adolescents. Cushing’s syndrome most commonly affects adults ages 20-50 and is more prevalent in females, accounting for about 70 percent of all cases.
In addition, increased disposable income in the emerging economies and growing healthcare expenditure coupled with the rising adoption of non-invasive treatment are also accelerating the growth of global cushing’s syndrome and acromegaly treatment market. Furthermore, increasing government initiatives for the growth in awareness and development of healthcare infrastructure are also supplementing the market growth. Increasing research and development to develop more innovative and effective treatments for cushing’s syndrome and acromegaly is also fostering the market growth. Recently, several techniques have been developed to aid in the early identification and monitoring of acromegaly and its associated complications. These advances in disease identification have led to a rise in the number of patients diagnosed with the disease and the development of better treatment modalities. This, in turn, will result in increased cure and decreased mortality rates in acromegaly patients.
However, lack of awareness regarding the latest treatments in the underdeveloped economies and the high cost of drugs may hamper the market growth. Moreover, increasing technological advancements for more innovative and effective treatments can provide various opportunities for the further growth of global cushing’s syndrome and acromegaly treatment market.
North America is Expected to Dominate the Global Cushing’s Syndrome and Acromegaly Treatment Market
The global cushing’s syndrome and acromegaly treatment market is segmented into North America, Europe, Asia-Pacific Latin America and Middle East & Africa. North America is expected to dominate the global cushing’s syndrome and acromegaly treatment market within the forecast period attributed to the highly developed healthcare infrastructure and availability highly advanced healthcare solutions in this region. Europe is projected to capture the second largest share of global cushing’s syndrome and acromegaly treatment market owing to the presence of leading players in this region. Asia Pacific is anticipated to witness a significant growth with a highest CAGR owing to the imroving healthcare infrastructure and increasing research and development for new and more effective treatments in this region.
Key Benefits for Global Cushing’s Syndrome and Acromegaly Treatment Market Report–
Global Cushing’s Syndrome and Acromegaly Treatment Market report covers in-depth historical and forecast analysis.
Global Cushing’s Syndrome and Acromegaly Treatment Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
Global Cushing’s Syndrome and Acromegaly Treatment Market report helps to identify opportunities in marketplace.
Global Cushing’s Syndrome and Acromegaly Treatment Market report covers extensive analysis of emerging trends and competitive landscape.
Buy this Report @ https://brandessenceresearch.biz/Buy/Create?ResearchPostId=141615&RequestType=Buy&PurchasePlan=SingleUser
Global Cushing’s Syndrome and Acromegaly Treatment Market Segmentation:-
By Drug Type:
Cushing’s Syndrome Treatment
Somatostatin
Ketoconazole HRA
Glucocorticoid Receptor Inhibitors
Other Off-label
Acromegaly Treatment
Glucocorticoid Receptor Inhibitors
Somatostatin
Other Off-label
By Sales Channel:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Regional & Country Level:
North America
U.S.
Canada
Europe
U.K.
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Cushing’s Syndrome and Acromegaly Treatment Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Cushing’s Syndrome and Acromegaly Treatment Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Cushing’s Syndrome and Acromegaly Treatment Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global Cushing’s Syndrome and Acromegaly Treatment Market Overview: Quantitative Analysis
4. Chapter – Global Cushing’s Syndrome and Acromegaly Treatment Market Analysis: By Type
5. Chapter – Global Cushing’s Syndrome and Acromegaly Treatment Market Analysis: By Application
6. Chapter – Global Cushing’s Syndrome and Acromegaly Treatment Market Analysis: By Manufacturer
6.1. Global Cushing’s Syndrome and Acromegaly Treatment Market Revenue (USD Million), by Manufacturer, 2014 – 2025
6.2. Global Cushing’s Syndrome and Acromegaly Treatment Market Share (%), by Manufacturer, 2018
6.3. Global Cushing’s Syndrome and Acromegaly Treatment Market Sales (Number of Units), by Manufacturer, 2014 – 2025
6.4. Global Cushing’s Syndrome and Acromegaly Treatment Market Share (%), by Manufacturer, 2018
6.5. Global Cushing’s Syndrome and Acromegaly Treatment Market Price (USD/Unit), by Manufacturer, 2014 – 2025
6.6. Global Cushing’s Syndrome and Acromegaly Treatment Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at alan@brandessenceresearch.biz
Website: https://brandessenceresearch.biz
Related Report:
Medical Devices Industry Reports 2019
Silicon Powder Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025
Lithium Sulfides Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025
